• Duphat 2026 MedEdge MEA
  • Dubai Derma 2026 DWTC
  • GHE Riyadh 2026 MedEdge
MedEdge MEA

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: M42 and HealthPlus Convene Multidisciplinary Forum on Diabetes Technology in Abu Dhabi
Share
Notification
  • Duphat 2026 MedEdge MEA
  • Dubai Derma 2026 DWTC
  • GHE Riyadh 2026 MedEdge
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In

Home - Medical Education - M42 and HealthPlus Convene Multidisciplinary Forum on Diabetes Technology in Abu Dhabi

Medical Education

M42 and HealthPlus Convene Multidisciplinary Forum on Diabetes Technology in Abu Dhabi

ME Desk
ME Desk
Published: June 27, 2026
Share
2 Min Read
M42 and HealthPlus Convene.jpg
SHARE
google_preferred_source_badge_light_en@2x

Over 500 healthcare professionals attended the third Diabetes Education and Technology Conference in Abu Dhabi on 20 and 21 June, as organisers brought together clinicians from multiple disciplines to examine the growing role of technology in diabetes care.


The event was jointly hosted by M42’s Imperial College London Diabetes and Endocrine Centre and HealthPlus Diabetes and Endocrinology Centre at the Grand Hyatt Abu Dhabi. Attendees spanning nursing, pharmacy, dietetics, diabetes education, and allied health convened to review technologies including continuous glucose monitoring, automated insulin delivery systems, and AI-enabled digital health tools.

Also read: Major Healthcare Initiative to Boost Hospital Services and Oxygen Supply in Sudan


Four hands-on workshops were introduced this year following feedback from previous delegates, aimed at narrowing the gap between technological development and practical clinical application.

M42 and HealthPlus Convene 3 .jpg


The conference was framed around a pressing global context. Data from the International Diabetes Federation indicates that around 589 million adults worldwide are currently living with diabetes, approximately one in nine people in the 20 to 79 age group. Organisers cited the pace of change in diabetes technology as a key reason for bringing professionals together to build applied competency alongside theoretical knowledge.

Click here to join our WhatsApp channel here


Faculty members and speakers numbered more than 30, with sessions combining expert presentations and peer exchange to support professionals in integrating emerging tools into routine clinical decision-making.


The UAE has seen growing investment in diabetes-focused education and research in recent years, with events of this nature positioned as part of a broader effort to strengthen the clinical workforce’s readiness for an increasingly technology-driven care environment.

GHE Riyadh 2026 MedEdge
Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article Department of Health Abu Dhabi 2 .jpg Department of Health Abu Dhabi and Novartis Forge genomics partnership to advance precision care
Next Article WHO Issues New Guidance.jpg WHO issues new guidance on Bundibugyo Virus Disease therapeutic research

Recent Posts

  • Is your filtered water safe to drink? UAE households question the safety of drinking water
  • Egypt to Launch Africa’s First Virtual Hospital to Expand Digital Healthcare
  • Mental health leaders commit to expanding rights-based care across West and Central Africa
  • Republic of Korea Contributes US$7.95 Million to Support Children in Syria
  • MBRU Earns International Accreditation for Continuing Medical Education
  • DERMA
  • Global Health Riyadh 2026 MedEdge MEA
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: M42 and HealthPlus Convene Multidisciplinary Forum on Diabetes Technology in Abu Dhabi
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: M42 and HealthPlus Convene Multidisciplinary Forum on Diabetes Technology in Abu Dhabi
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?